Ataxia-telangiectasia (AT) is a complex, autosomal recessive disorder characterized by cerebellar ataxia, believed to result from progressive neurodegeneration, and telangiectasia, dilation of blood vessels within the eyes and parts of the facial region. AT patients suer from recurrent infections caused by both cellular and humoral immune de®ciencies and as a population, are signi®cantly predisposed to cancer, particularly lymphomas and leukemias. Early attempts at treating these malignancies with radiotherapy revealed another hallmark of AT, a profound hypersensitivity to the cytotoxic eects of ionizing radiation (IR) which is recapitulated at the cellular level in culture. Predisposition to cancer and radiosensitivity observed in AT has been linked to chromosomal instability, abnormalities in genetic recombination, and defective signaling to programmed cell death and several cell cycle checkpoints activated by DNA damage. These earlier observations predicted that the gene defective in AT may encode a protein which plays a crucial role in sensing DNA damage and transducing signals that promote cell survival. Through the combined eorts of linkage analysis and positional cloning, a single gene was identi®ed on chromosome 11q22-33 by Shiloh and colleagues and was found to be mutated in all four complementation groups previously characterized in cell lines derived from AT patients (Savitsky et al., 1995a,b) . The predicted ATM gene product shows considerable homology to an emerging family of high molecular weight, phosphatidylinositol -3 kinase (PI-3 K)-related proteins involved in eukaryotic cell cycle control, DNA repair, and DNA recombination (Zakian, 1995) . This landmark discovery has triggered a resurgence of biochemical and genetic studies focusing on ATM function which has brought forth insights regarding ATM activity and its role in DNA damage signaling.
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AT phenotype
Early eorts directed towards understanding the unusual radiosensitivity of cultured AT cells have identi®ed numerous abnormalities in the way these cells respond to DNA damage. First, AT cells only display abnormal sensitivity to IR or agents which in¯ict similar types of damage upon DNA. In contrast, AT cells appear to have relatively normal responses to ultra-violet (UV) radiation or alkylating agents indicating that ATM is only required for cellular responses to speci®c types of DNA damage (McKinnon, 1987) . Second, AT cells are defective in activating several cell cycle checkpoints in response to IR. AT cells fail to arrest in the G1 phase of the cell cycle due to a lack of or prolonged delay in their ability to induce the p53 tumor suppressor gene product (Kastan et al., 1992; Morgan and Kastan, 1997b) . Consequently, these cells do not eciently transactivate p53-responsive genes including p21(WAF1/Cip1), whose gene product is largely responsible for growth arrest in G1 by inhibiting G1 cyclin-dependent kinase activity (El-Deiry et al., 1994; Dullic et al., 1994; Waldman et al., 1995) . Defective p53 induction is only observed in AT cells treated with IR, and not UV Khanna and Lavin, 1993) .
Another hallmark phenotype of AT cells is the display of radioresistant DNA synthesis, a term used to describe the inability of AT cells to rapidly downregulate DNA synthesis after exposure to IR (Houldsworth and Lavin, 1980; Painter and Young, 1980) . This acute response to IR is distinguishable from the G1 cell cycle checkpoint by its independence of p53 status (Larner et al., 1994) . The continued progression of AT cells through G1 and S ultimately leads to a sustained accumulation of cells in the G2 (Beamish and Lavin, 1994) . In fact, AT cells require a longer period of time to recover from G2 arrest after IR as compared to normal cells. Paradoxically, if AT cells are in the G2 phase of the cell cycle at the time of irradiation, they inappropriately progress into mitosis and signi®cantly higher numbers of chromosomal gaps and breaks per mitotic spread are evident (Beamish and Lavin, 1994; Beamish et al., 1997; Morgan et al., 1997; Paules et al., 1995) . The lack of G2 delay may be due to a failure in rapidly downregulating cyclin B-dependent cdc2 kinase activity in response to IR (Paules et al., 1995; Beamish et al., 1997) . Thus, it depends on where in the cell cycle an AT cell is at the time of irradiation as to what type of checkpoint abnormality is observed. There is no evidence suggesting that the defect in the G1 cell cycle checkpoint is responsible for radiosensitivity since cells lacking functional p53 are equally sensitive as their wild type p53 expressing counterparts (Slichenmyer et al., 1993) . Replicating a damaged DNA template or attempting mitosis with unrepaired chromosomes can at least partially explain the radiosensitivity of AT cells.
Increased sensitivity to p53-dependent apoptosis has been suggested as an alternative explanation of radiosensitivity in AT (Meyn et al., 1994; Meyn, 1995) . However, the majority of evidence indicates that in most cases, cells defective in ATM are either normal or de®cient in their ability to undergo apoptosis in response to IR, although AT cells have been observed to be more sensitive to undergoing spontaneous apoptosis in culture (Enns et al., 1998; Barlow et al., 1997; Herzog et al., 1998; Westphal et al., 1997; Duchaud et al., 1996; Elson et al., 1996) . In fact, a signi®cant component of radiosensitization caused by loss of ATM function may be largely independent of p53 status suggesting that enhanced p53-dependent apoptosis is not the primary cause of radiosensitization in AT (Westphal et al., 1998) .
Radioresistance, rather than radiosensitization, has been observed in select AT null tissues known for their dependence upon p53 function for execution of the apoptotic pathway in response to IR. Herzog et al. (1998) described profound resistance to IR-induced apoptosis within the developing central nervous system (CNS) of ATM7/7 mice. The dependence on ATM for the induction of cell death was observed throughout diverse regions of the CNS including the cerebellum, which is interestingly the site of neurodegeneration in AT patients. These same tissues were also defective in p53 induction following IR and were correspondingly resistant to IR-induced apoptosis in p537/7 mice indicating a strong regulatory role for ATM in signaling to p53 in these tissues (Herzog et al., 1998; Wood and Youle, 1995; Enokido et al., 1996) .
Like the developing CNS, immature thymocytes are extremely sensitive to IR-induced apoptosis that is strictly dependent upon functional p53 expression (Lowe et al., 1993; Clarke et al., 1993) . Thus, it was not surprising to ®nd thymocytes from ATM7/7 mice to be at least partially resistant to apoptosis induced by IR due to the dependence of p53 function on ATM Westphal et al., 1997) . Upon closer examination however, Barlow et al. (1997) found that when analysed at early time points after exposure of ATM7/7 mice to IR, thymocyte p53-dependent apoptosis appeared to be perfectly normal, even though G1 cell cycle checkpoint function was abrogated. As expected, p53 and p21 induction following IR was attenuated in ATM7/7 thymocytes but the p53-responsive, pro-apoptotic Bax protein was induced with similar eciency as in normal thymocytes strongly suggesting the existence of ATM-independent pathways that regulate p53 transcriptional activity and p53-dependent apoptosis in response to IR . Therefore, whether ATM function is required for cells to undergo apoptosis in response to IR depends upon the extent to which ATM is required for modulating p53-mediated apoptosis in what appears to be a distinct tissue-speci®c manner.
Thus far, investigators have been largely unsuccessful in identifying speci®c DNA repair defects in irradiated AT cells (McKinnon, 1987) . However, a signi®cant amount of evidence suggests that AT cells may have some subtle DNA repair defect. It has been known for years that lymphocytes isolated from AT patients contain unusually high frequencies of spontaneous chromosomal rearrangements and telomeric fusions as compared to those obtained from normal individuals (Kojis et al., 1991) . Accelerated telomere shortening has also been noted in peripheral blood lymhocytes isolated from AT patients with increasing age . In culture, elevated rates of intra-and extra-homologous recombination events have been detected in AT cells coupled with a possible defect in the nonhomologous end joining (NHEJ) or illegitimate recombinational repair pathway (Meyn, 1993; Luo et al., 1996; Dar et al., 1997) . AT cells also exhibit higher numbers of chromosomal gaps and breaks that persist for longer periods of time after IR exposure (Cornforth and Bedford, 1985; Morgan et al., 1997) . Both radiosenstivity and IR-induced chromosomal instability appear to be separable from the cell cycle checkpoint defects characteristic of AT cells (Cornforth and Bedford, 1985; Morgan et al., 1997; Jeggo et al., 1998) . Therefore, failure to arrest in G1 or G2 after IR cannot solely account for enhanced chromosomal abberations and radiosensitivity in AT cells suggesting a distinct defect in the way DNA double strand breaks (DSBs) are processed (Jeggo et al., 1998) .
Patients with the rare autosomal recessive Nijmegen breakage syndrome (NBS) share many of the same clinical features as AT patients and at the cellular level have strikingly similar abnormalities in IR-induced responses including defects in the activation of cell cycle checkpoints (Shiloh, 1997) . The gene product defective in NBS, p95 or nibrin, is a component of the large multiprotein complex containing hRad50 and hMre11, nuclear proteins implicated in the NHEJ recombinational DNA repair pathway (Varon et al., 1998; Carney et al., 1998; Dolganov et al., 1996; Featherstone and Jackson, 1998) . In response to IR, hMre11 and hRad50 form nuclear foci in close proximity to DSBs and the formation of these foci is markedly reduced in both NBS and AT cells (Maser et al., 1997; Dolganov et al., 1996; Carney et al., 1998; Nelms et al., 1998) . Interestingly, AT cells form unusually high numbers of foci containing the homologous recombinational repair protein, hRad51 (Maser et al., 1997) . These results are surprisingly consistent with earlier reports describing elevated rates of homologous recombination and defective NHEJ repair using plasmid based assays in AT cells (Meyn, 1993; Luo et al., 1996; Dar et al., 1997) . These results directly link ATM to the regulation of recombinatorial DNA repair and suggest that the same signals involved in regulating the recruitment of hMre11 and hRad50 to DSBs may also be involved in supporting ATMdependent signaling as well.
Loss of ATM and tumorigenesis
In addition to radiosensitivity, another hallmark feature of AT is profound cancer predisposition evident by 10 ± 15% of patients being diagnosed with lymphomas and acute lymphocytic leukemias at an early age . The relative risk for developing these particular tumor types is several hundred-fold higher in AT as compared to the normal population (Swift et al., 1987) . These tumors typically originate from T-cells and harbor the same gene rearrangements of immunoglobulin and T-cell receptor gene families frequently observed in nonmalignant circulating T-lymphocytes in AT patients (Kojis et al., 1991) . AT patients also exhibit an increased risk for the development of epithelial tumors later in life and AT heterozygotes may share a small but measurable risk for developing breast cancer (Swift et al., 1987; Uhrhammer et al., 1998) . ATM may also play a role as a classic tumor suppressor in T-prolymphocytic leukemia, which is highly associated with loss or mutation in the ATM locus (Vorechovsky et al., 1997) . In addition, frequent loss in heterozygocity (LOH) at the 11q22-q23 loci has been reported for several other cancers as well, including breast cancer (Hampton et al., 1994a,b; Gabra et al., 1996; Winqvist et al., 1995) . However, at this point in time, it is not known whether ATM is the critical tumor suppressor gene at this locus since other candidate genes have been identi®ed within this region (Negrini et al., 1995; Laake et al., 1997; Monaco et al., 1998) .
The increased risk for cancer has been recreated in ATM7/7 mice and similar to AT patients, a large percentage of tumors are thymic lymphomas displaying multiple chromosomal aberrations (Barlow et al., 1996; Elson et al., 1996) . Even more striking, is the predominance of same types of thymic tumors occurring in both ATM7/7 and p537/7 mice (Donehower et al., 1992; Jacks et al., 1994; Purdie et al., 1994) . Therefore, eliminating ATM, a primary sensor required for signaling to p53 in certain physiological settings, results in a similar cancer susceptibility phenotype that is observed when p53 function is disrupted (Hawley and Friend, 1996) . The ability of p53 to suppress oncogenesis has been linked to its abilities to mediate G1 cell cycle arrest, promote genetic stability, and trigger apoptosis in response to DNA strand breaks caused by genotoxic agents and programmed gene rearrangements (Morgan and Kastan, 1997b; White, 1996; Canman and Kastan, 1997) . Tumor formation is dramatically accelerated in mice lacking both p53 and ATM as compared to mice having deletions in either gene alone suggesting that one or both of these proteins possess additional, independent functions in suppressing tumorigenesis (Westphal et al., 1997) . The challenge for the future will be to determine whether cancer susceptibility in AT is primarily due to the loss of a critical signaling pathway to p53 or to parallel pathways that govern the transition through other phases of the cell cycle or regulate chromosomal repair (Meyn, 1995; Hartwell and Kastan, 1994; Jeggo et al., 1998) .
ATM protein
ATM is a member of a growing family of high molecular weight protein kinases that share sequence similarities within a unique carboxyl-terminal domain related to classical PI-3 kinases (Keith and Schreiber, 1995) . Functionally, PI-3 kinase-related proteins can be divided into two groups. The ®rst group includes the S. cerevisiae TOR1 and TOR2 proteins and mammalian homologs FRAP/RAFT1/mTOR, all of which participate in G1/S cell cycle progression and are targets for the rapamycin-FKBP12 complex (Kunz et al., 1993; Helliwell et al., 1994; Brown et al., 1994; Sabatini et al., 1994; Sabers et al., 1995) . In general, the other family members are necessary for proper responses to DNA damage and cells individually lacking expression of several of these gene products share many of the same phenotypes as AT cells. The essential MEC1/ ERS1 protein is required for the majority of responses observed in S. cerevisiae including the DNA replication and damage checkpoint pathways, transcriptional activation of DNA damage-responsive genes, meiotic recombination and DNA repair (Weinert et al., 1994; Kato and Ogawa, 1994) . Structural and functional homologs of MEC1 include the Drosophila melanogaster Mei-41 protein, the S. Pombe Rad3 protein, and the mammalian AT-and Rad3-related ATR/FRP1 protein (Hari et al., 1995; Bentley et al., 1996; Cimprich et al., 1996) . The closest homolog to ATM in sequence similarity is the S. cerevisiae TEL1 gene product, deletions of which results in the shortening of telomeres (Morrow et al., 1995; Greenwell et al., 1995) . Although TEL1 does not appear to play a major role in checkpoint function or viability, overexpression of TEL1 in a MEC1 mutant can rescue from cell death suggesting some functional redundancies between these two family members (Morrow et al., 1995) . Some functional overlap also may exist between ATM and ATR/FRP1 since overexpression of the latter has recently been shown to partially complement radiosentivity and radioresistant DNA synthesis in AT ®broblasts (Cliby et al., 1998) . The catalytic subunit of DNA-dependent protein kinase (DNA-PKcs), the most distant member of the family, is implicated in DNA double-strand break repair and V(D)J recombination (Hartley et al., 1995a; Jackson, 1996) . DNA-PK is a multiprotein complex consisting of the catalytic subunit and two tightly associated DNA binding proteins, Ku70 and Ku80, which direct DNA-PKcs to DNA and greatly enhance kinase activity (Jackson, 1996) .
ATM is a phosphoprotein that is detectable in all tissues examined with higher levels of expression observed in the testis, spleen, and thymus (Chen and Lee, 1996) . The majority of mutations found in the ATM gene are predicted to give rise to truncated proteins (Savitsky et al., 1995a; Gilad et al., 1996; Telatar et al., 1996; Wright et al., 1996; Ziv et al., 1997; Concannon and Gatti, 1997) . In many cases, the truncated forms of ATM protein appear to be highly unstable as indicated by the diculty in detecting such forms by immunoblot analysis Lakin et al., 1996; Brown et al., 1997) . Importantly, ectopic expression of the full length cDNA clone for ATM rescues radiosensitivity and corrects many of the cell cycle checkpoints defective in AT cells Ziv et al., 1997) . Expression of a carboxyterminal fragment of ATM containing the PI-3 kinaserelated domain in AT ®broblasts complements some of the phenotypes associated with AT. This included enhanced survival after IR, restoration of IR-induced S phase arrest, and reduction of chromosomal instability suggesting that many functions of ATM protein reside within the catalytic PI-3 kinase-related domain .
Further examination of ATM protein sequence reveals the existence of a putative leucine zipper motif suggestive of a protein-protein interaction domain. Expression of a protein fragment containing the leucine zipper domain of ATM in normal cells results in a dominant negative eect, creating several, but not all, of the abnormalities observed in AT cells. Irradiated cells expressing this fragment lost the S phase checkpoint, became radiosensitized and exhibited an increase in chromosomal instability . The identity of proteins which may interact with the putative leucine zipper domain of ATM is unknown; however, both DNA-PK and ATR/FRP1 share such a region. In the case of DNA-PKcs, this domain was recently described to associate with high anity to C1D, a DNA binding protein that is capable of activating the catalytic subunit of DNA-PK in addition to serving as a substrate for kinase activity in vitro (Yavuzer et al., 1998) . Interestingly, C1D is also induced by DNA damage (Yavuzer et al., 1998) .
Based on the evidence that ATM participates in signaling induced by DNA damage, it was not surprising to ®nd the majority of ATM protein associated with the nucleus Watters et al., 1997; Lakin et al., 1996; Chen and Lee, 1996; Brown et al., 1997; Gately et al., 1998) . Immunoelectron microscopy and cellular fractionation studies indicate that at least in certain cell types, a signi®cant fraction of ATM protein also localizes to cytoplasmic vesicles Brown et al., 1997) . Consistent with multiple subcellular localizations, ATM has recently been found to associate with badaptin, a component of the AP-2 adaptor complex which is involved in clathrin-mediated endocytosis of extracellular receptors . Other observations support extranuclear roles for ATM. AT cells in culture exhibit additional abnormalities such as altered actin cytoskeleton, higher levels of growth factors required for cell growth in culture, and defective B-cell receptor signaling (McKinnon and Burgoyne, 1985; Shiloh et al., 1982; Khanna et al., 1997) . ATM is not the only family member associated with cytoplasmic vesicles. TOR2 has been localized to vacuoles in budding yeast and also plays an essential role in the organization of actin cytoskeleton during the cell cycle (Cardenas and Heitman, 1995; Schmidt et al., 1996 Schmidt et al., , 1997 ).
ATM and signal transduction
As a result of the extensive analyses of biochemical anomalies present in AT cells, numerous potential targets of ATM have been speculated upon. Both p53 and the 34 kD subunit of the replication protein A (RPA) complex are phosphorylated in response to IR in an ATM-dependent manner (Shieh et al., 1997; Siliciano et al., 1997; Sakaguchi et al., 1998; Liu and Weaver, 1993; Cheng et al., 1996) . Both of these proteins are robustly phosphorylated by DNA-PK in vitro suggesting that ATM may share similar substrate speci®cities with DNA-PK, namely sequences containing serine/glutamine motifs (Lees-Miller et al., 1992; Bannister et al., 1993; Brush et al., 1994; Niu et al., 1997) . Consistent with this possibility, DNA-PK phosphorylates p53 on the same site in vitro (Serine 15) which is phosphorylated in vivo in response to DNA damage (Shieh et al., 1997; Siliciano et al., 1997) . This creates an enormous caveat for investigators developing in vitro kinase assays for ATM, since they are forced to prove that the kinase activity being measured in their assay is truly ATM and not a contaminant of DNA-PK. However, recent evidence demonstrates that there are de®nitive biochemical dierences between DNA-PK and ATM. First, ATM protein kinase activity is strictly dependent upon Mn +2 , a requirement not displayed by DNA-PK Banin et al., 1998; Gottlieb and Jackson, 1993; Lees-Miller et al., 1990) . And second, ATM does not appear to require DNA ends to activate its kinase activity in vitro Banin et al., 1998) . One property shared by both ATM and DNA-PK is their sensitivity to the PI-3 kinase inhibitor, wortmannin, which has recently been shown to eectively radiosensitize cells and abrogate the S phase checkpoint suggesting that wortmannin may eectively inhibit ATM kinase activity in intact cells (Hartley et al., 1995; Sarkaria et al., 1998) .
ATM has been strongly implicated in regulating phosphorylation and induction of p53 in cells exposed to IR (Kastan et al., 1992; Khanna and Lavin, 1993; Canman et al., 1994; Siliciano et al., 1997; Watters et al., 1997) . Direct evidence in support of this comes from recent demonstrations that ATM kinase is capable of phosphorylating p53 on serine 15 in vitro and its kinase activity is enhanced in cells exposed to IR or a radiomimetic compound in a DNA damage-speci®c manner Banin et al., 1998) . Phosphorylation of p53 at serine 15 weakens its ability to interact with the mdm2 oncoprotein (Shieh et al., 1997) . Mdm2 functions to both inhibit transactivation by p53 and regulate its half-life by targeting p53 for rapid proteolytic degradation when bound to p53 (Momand et al., 1992; Oliner et al., 1993; Haupt et al., 1997; Kubbutat et al., 1997; Honda et al., 1997) . Together, these results combine to form an attractive model where phosphorylation of serine 15 in response to DNA damage contributes to the stabilization of p53 by limiting its interaction with mdm2 (Prives, 1998) . The fact that UV induces serine 15 phosphorylation and stabilization of p53 in AT cells and fails to activate the ATM kinase (Siliciano et al., 1997; Canman et al., 1998) is strong evidence that other protein kinases are also involved in regulating serine 15 phosphorylation in response to DNA damage. In addition to DNA-PK, ATR/FRP1 may be such a candidate kinase .
The regulation of p53 post-translational modifications in response to IR is not limited to phosphorylation events. Using phospho-speci®c antibodies, Waterman et al. (1998) identi®ed ATM-dependent dephosphorylation of serine 376 in cells exposed to IR suggesting that ATM may activate a p53-speci®c phosphatase in response to IR. Both serine 376 and 378 within the carboxy-terminal domain are constitutively phosphorylated in non-irradiated cells. IR induces rapid dephosphorylation of serine 376 which correlates with association of 14-3-3 proteins with p53. Binding of 14-3-3 proteins to p53 is not observed in AT cells exposed to IR and in vitro, association of 14-3-3 with p53 leads to enhanced DNA binding activity. These results are consistent with previous ®ndings that the carboxy-terminal region of p53 is an important regulatory domain for sequence speci®c DNA binding activity that can be aected by both phosphorylation and acetylation (Ko and Prives, 1996; Giaccia and Kastan, 1998) .
The regulation of p53 DNA binding activity is becoming increasingly complex. Just as DNA-PK began to lose its status as the candidate in vivo kinase responsible for phosphorylating p53 on serine 15 in response to IR, it has now been assigned a new role in regulating p53 DNA binding activity. This discrepancy arose from earlier ®ndings that cells obtained from combined immunode®ciency scid mice, whose DNA-PK activity is compromised, were competent in their ability to induce p53 and undergo G1 arrest in response to IR (Rathmell et al., 1997; Guidos et al., 1997; Nacht et al., 1997) . Upon closer examination of the cell lines used in the previous studies, Woo et al. (1998) observed that those cell lines still possess detectable DNA-PK activity. When a murine SCID cell line completely lacking detectable DNA-PK activity was examined for its p53 response following IR, normal accumulation of p53 levels occurs but the induced p53 is de®cient in its ability to transactivate the p21(WAF1/Cip1) gene (Woo et al., 1998) . This de®ciency in transcriptional activity was traced to an inability of p53 to bind DNA in a sequence speci®c manner and can be corrected in vitro through the addition of puri®ed DNA-PK and another DNA-PKindependent factor obtained from irradiated cell extracts (Woo et al., 1998) . The ability of DNA-PK to regulate the binding activity of p53 is probably independent of serine 15 or 37 phosphorylation alone since this post-translation modi®cation by itself does not appear to aect the ability of p53 to bind DNA in a sequence-speci®c manner (Shieh et al., 1997) . However, phosphorylation of recombinant p53 at serines 15 and 37 by DNA-PK does appear to positively aect the ability of histone acetyltransferases to subsequently acetylate p53 at the carboxyterminus in vitro and this is known to enhance p53 DNA binding activity (Gu and Roeder, 1997; Sakaguchi et al., 1998) . Interestly, Sakaguchi et al. (1998) have recently shown that lysine 382 is acetylated in response to DNA damage in cells. It remains to be determined whether this event depends upon ATM.
Phosphorylation of the p34 subunit of the ssDNAbinding protein, RPA, in response to IR has been speculated as a potential mechanism to regulate the S phase checkpoint or modulate DNA repair (Wold, 1997) . The observations that this event is defective in AT cells or budding yeast harboring mutated MEC1 has implicated RPA as a direct target of ATM (Liu and Weaver, 1993; Cheng et al., 1996; Brush et al., 1996) . Recent evidence suggests that RPA may in fact be a direct substrate for the ATM kinase in vitro (Gately et al., 1998) . Whether RPA phosphorylation is directly involved in the S phase checkpoint is certainly unclear and furthermore, DNA-PK may also be involved in this response as well (Morgan and Kastan, 1997a; Boubnov and Weaver, 1995) . However, it is intriguing that both ATM and RPA colocalize along synapsed meiotic chromosomes in normal murine spermatocytes, and in ATM7/7 spermatocytes, RPA is preferentially localized at sites of chromosomal fragmentation typically observed in ATM7/7 spermatocytes attempting meiosis Plug et al., 1997) .
The non-receptor tyrosine kinase c-Abl and the stressactivated Jun kinases (JNKs) may also participate in ATM-dependent signaling in response to DNA damaging agents, although with some controversy. Thus far, the consensus is that IR-induced activation of c-Abl kinase activity is de®cient in AT cells and c-Abl may in turn be necessary for ecient IR-induced activation of JNKs (Shafman et al., , 1997 Baskaran et al., 1997; Kharbanda et al., 1995) . Consistent with these results, ATM and c-Abl can be co-immunoprecipitated from cell lysates and overexpression of the carboxy-terminal kinase domain of ATM in AT cells can restore IRinducible c-Abl activation as well as complement several phenotypic abnormalities observed in AT cells (Baskaran et al., 1997; Shafman et al., 1997; Morgan et al., 1997) . However it is unclear what role c-Abl plays in the cellular response to DNA damage since immortalized murine c-Abl null ®broblasts appear to have normal checkpoint functions activated by IR, including the induction of p53 (Liu et al., 1996) . Previous studies suggested a cell cycle regulatory role for c-Abl through demonstrations that overexpression of c-Abl results in p53-dependent growth arrest in murine embryonic ®broblasts and this activity correlates with downregulation of cyclin-dependent cdk2 kinase activity (Goga et al., 1995; Yaun et al., 1996) . In addition, c-Abl and p53 appear to associate with one another in irradiated cells and in this particular study, c-Abl null murine ®broblasts were defective in the G1 cell cycle checkpoint (Yaun et al., 1996) . Perhaps not surprising, DNA-PK also associates with c-Abl in vivo and can phosphorylate c-Abl in vitro . Furthermore, cells de®cient in DNA-PK activity are also de®cient in their ability to activate c-Abl suggesting the intriguing possibility that for optimal activation or phosphorylation of p53, RPA, and c-Abl in response to IR, ATM and DNA-PK may be interdependent upon one another. However, more studies are clearly needed to resolve the true function of c-Abl in DNA damage responses.
Conclusion
Since the identi®cation of the ATM gene, signi®cant progress has been made in characterizing the biochemistry of this large multifunctional protein. Future studies will certainly reveal new targets for the ATM protein kinase and hopefully we will begin to understand why functional loss of this protein results in a disorder characterized by such a diverse array of phenotypic abnormalities. Perhaps the biggest challenge will be to determine whether the clinical manifestations observed in AT patients are mainly caused by attenuated responses to DNA damage or whether ATM is crucial for additional cellular functions which have thus far escaped our detection.
